As the pet market grows, pet owners and certain pet industry professionals are paying increasing attention to genetic diseases. However, existing genetic testing technologies are costly and rely on imports, which limits their widespread adoption in the market. Precision BioHealth has developed a localized, rapid, and cost-effective canine genetic testing kit that provides accurate and fast testing services for genetic diseases common among dogs in Taiwan, thereby lowering the barrier to testing and increasing market acceptance. In the future, the company will raise pet owners’ awareness of genetic testing through market education and regulatory advocacy, while collaborating with breeders, veterinary clinics, and pet insurance companies. The goal is to establish a comprehensive health and pedigree management service. In the short term, the company will focus on the Taiwanese market to increase testing penetration; in the medium to long term, it will expand into the Asia-Pacific market to become a leading brand in pet genetic testing, driving industry upgrading, animal welfare, and sustainable development.